Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Transcriptional signature primes human oral mucosa for rapid wound healing.

Iglesias-Bartolome R, Uchiyama A, Molinolo AA, Abusleme L, Brooks SR, Callejas-Valera JL, Edwards D, Doci C, Asselin-Labat ML, Onaitis MW, Moutsopoulos NM, Gutkind JS, Morasso MI.

Sci Transl Med. 2018 Jul 25;10(451). pii: eaap8798. doi: 10.1126/scitranslmed.aap8798.

PMID:
30045979
2.

Epidermal loss of Gαq confers a migratory and differentiation defect in keratinocytes.

Doçi CL, Mikelis CM, Callejas-Valera JL, Hansen KK, Molinolo AA, Inoue A, Offermanns S, Gutkind JS.

PLoS One. 2017 Mar 16;12(3):e0173692. doi: 10.1371/journal.pone.0173692. eCollection 2017.

3.

Using Heterologous COS-7 Cells to Identify Semaphorin-Signaling Components.

Sakurai A, Doçi CL, Gutkind JS.

Methods Mol Biol. 2017;1493:163-170.

PMID:
27787849
4.

Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma.

Doçi CL, Mikelis CM, Lionakis MS, Molinolo AA, Gutkind JS.

Cancer Res. 2015 Jul 15;75(14):2937-48. doi: 10.1158/0008-5472.CAN-14-3121. Epub 2015 May 7.

5.

SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.

Dillenburg-Pilla P, Patel V, Mikelis CM, Zárate-Bladés CR, Doçi CL, Amornphimoltham P, Wang Z, Martin D, Leelahavanichkul K, Dorsam RT, Masedunskas A, Weigert R, Molinolo AA, Gutkind JS.

FASEB J. 2015 Mar;29(3):1056-68. doi: 10.1096/fj.14-260083. Epub 2014 Dec 2.

6.

The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression.

Doçi CL, Zhou G, Lingen MW.

Oncogene. 2013 Sep 12;32(37):4377-86. doi: 10.1038/onc.2012.464. Epub 2012 Oct 22.

PMID:
23085760
7.

DSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarrays.

Patel V, Martin D, Malhotra R, Marsh CA, Doçi CL, Veenstra TD, Nathan CA, Sinha UK, Singh B, Molinolo AA, Rusling JF, Gutkind JS.

Oral Oncol. 2013 Feb;49(2):93-101. doi: 10.1016/j.oraloncology.2012.08.001. Epub 2012 Sep 23.

8.

Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.

Sakurai A, Doçi CL, Gutkind JS.

Cell Res. 2012 Jan;22(1):23-32. doi: 10.1038/cr.2011.198. Epub 2011 Dec 13. Review. Erratum in: Cell Res. 2012 Feb;22(2):441. Doci, Colleen [corrected to Doçi, Colleen L].

9.

Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.

Doçi CL, Mankame TP, Langerman A, Ostler KR, Kanteti R, Best T, Onel K, Godley LA, Salgia R, Lingen MW.

Int J Gynecol Pathol. 2012 Jan;31(1):15-24. doi: 10.1097/PGP.0b013e318220ba16.

10.

Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.

Zhou G, Hasina R, Wroblewski K, Mankame TP, Doçi CL, Lingen MW.

Cancer Prev Res (Phila). 2010 Nov;3(11):1493-502. doi: 10.1158/1940-6207.CAPR-10-0135. Epub 2010 Oct 26.

11.

Identification and functional analysis of NOL7 nuclear and nucleolar localization signals.

Zhou G, Doçi CL, Lingen MW.

BMC Cell Biol. 2010 Sep 27;11:74. doi: 10.1186/1471-2121-11-74.

Supplemental Content

Support Center